UiPath (NYSE:PATH) Stock Price Down 0.7%

UiPath Inc. (NYSE:PATH - Get Free Report) shares fell 0.7% on Tuesday . The stock traded as low as $22.72 and last traded at $22.92. 1,678,349 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 9,641,169 shares. The stock had previously closed at $23.07.

Analyst Ratings Changes

Several brokerages recently weighed in on PATH. Royal Bank of Canada restated a "sector perform" rating and issued a $29.00 price target on shares of UiPath in a research report on Wednesday, March 20th. Evercore ISI lifted their price objective on shares of UiPath from $24.00 to $27.00 and gave the stock an "in-line" rating in a research note on Thursday, March 14th. BMO Capital Markets lifted their price objective on shares of UiPath from $24.00 to $28.00 and gave the stock a "market perform" rating in a research note on Thursday, March 14th. TD Cowen lifted their price objective on shares of UiPath from $25.00 to $28.00 and gave the stock an "outperform" rating in a research note on Thursday, March 14th. Finally, DA Davidson lifted their price objective on shares of UiPath from $20.00 to $24.00 and gave the stock a "neutral" rating in a research note on Thursday, March 14th. Nine analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, UiPath presently has a consensus rating of "Hold" and an average target price of $27.44.

UiPath Price Performance

The firm has a fifty day moving average of $23.61 and a two-hundred day moving average of $21.02. The stock has a market capitalization of $12.85 billion, a P/E ratio of -133.52 and a beta of 0.97.

Insider Activity at UiPath

In related news, Director Rich Wong sold 200,000 shares of UiPath stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $23.12, for a total value of $4,624,000.00. Following the completion of the sale, the director now directly owns 429,418 shares in the company, valued at $9,928,144.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the business's stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $22.47, for a total value of $359,520.00. Following the completion of the transaction, the chief financial officer now directly owns 103,505 shares in the company, valued at $2,325,757.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Rich Wong sold 200,000 shares of the business's stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $23.12, for a total transaction of $4,624,000.00. Following the completion of the transaction, the director now owns 429,418 shares of the company's stock, valued at $9,928,144.16. The disclosure for this sale can be found here. Insiders sold 427,000 shares of company stock worth $9,784,110 over the last three months. 31.03% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On UiPath

A number of large investors have recently added to or reduced their stakes in PATH. Quadrature Capital Ltd raised its position in shares of UiPath by 94.4% in the 4th quarter. Quadrature Capital Ltd now owns 253,112 shares of the healthcare company's stock valued at $6,289,000 after purchasing an additional 122,931 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of UiPath by 50.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 19,135 shares of the healthcare company's stock valued at $475,000 after purchasing an additional 6,385 shares during the last quarter. Vanguard Group Inc. raised its position in shares of UiPath by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 38,084,858 shares of the healthcare company's stock valued at $946,028,000 after purchasing an additional 334,085 shares during the last quarter. Gerber LLC purchased a new position in shares of UiPath in the 4th quarter valued at approximately $455,000. Finally, Sierra Summit Advisors LLC purchased a new position in shares of UiPath in the 4th quarter valued at approximately $5,897,000. 62.50% of the stock is currently owned by institutional investors.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.